UnitedHealth Group Incorporated (UNH) Stock Rating Reaffirmed by Mizuho
UnitedHealth Group Incorporated (NYSE:UNH)‘s stock had its “buy” rating reissued by research analysts at Mizuho in a research note issued on Tuesday.
The analysts wrote, “3Q17 adjusted cash EPS of $1.90, up 9.3% y/y, was $0.02 below our estimate of $1.92, but inline with consensus. GAAP EPS of $1.46, up 27.0% y/y, was above our estimate of $1.44, but below consensus of $1.49. The company slightly raised the lower end of its 2017 adjusted EPS guidance to $6.97-$7.05, from $6.95-$7.05, bracketing both our estimate of $7.00 and consensus of $6.99. ESRX appointed former interim CFO James Havel (January 2015-September 2015) as its CFO. He replaces Eric Slusser, who had served as CFO since September 2015.””
Several other research firms also recently weighed in on UNH. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th. Morgan Stanley upped their price objective on UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, June 28th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $190.00 price objective on shares of UnitedHealth Group in a research report on Monday, July 10th. Finally, Deutsche Bank AG upped their price objective on UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a research report on Thursday, July 13th. Three investment analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $215.27.
Shares of UnitedHealth Group (UNH) traded up 0.55% on Tuesday, hitting $208.15. 3,459,875 shares of the stock traded hands. The firm has a market cap of $205.86 billion, a PE ratio of 23.63 and a beta of 0.63. UnitedHealth Group has a 52-week low of $136.22 and a 52-week high of $208.45. The firm has a 50 day moving average price of $197.92 and a 200 day moving average price of $186.84.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.17 EPS. On average, equities analysts forecast that UnitedHealth Group will post $9.96 EPS for the current year.
WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/10/24/unitedhealth-group-incorporated-unh-stock-rating-reaffirmed-by-mizuho.html.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Thomas E. Roos sold 975 shares of the stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last quarter, insiders sold 77,149 shares of company stock valued at $15,182,242. 0.89% of the stock is currently owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the business. Blue Chip Partners Inc. acquired a new position in shares of UnitedHealth Group in the second quarter valued at about $110,000. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at about $114,000. Patriot Financial Group Insurance Agency LLC increased its holdings in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after purchasing an additional 603 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its holdings in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at about $121,000. Institutional investors own 86.09% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.